Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).

Molecular psychiatry - 1 Mar 2000

Yoshikawa T, Padigaru M, Karkera J D, Sharma M, Berrettini W H, Esterling L E, Detera-Wadleigh S D

Abstract excerpt

Recently, we cloned the human myo-inositol monophosphatase 2 (IMPA2) cDNA and established its map location to chromosome 18p11.2, a region previously implicated in bipolar disorder. Because the myo-inositol monophosphatase enzyme has been shown to be inhibited by lithium, an effective therapeutic agent for bipolar disorder, IMPA2 is a plausible positional and functional candidate gene. To permit comprehensive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alternative Splicing
Share to Bipolar Disorder

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 18

Share to Gene Library

Share to Introns

Share to Mutation, Missense

Share to Phosphoric Monoester Hydrolases

Share to Transcription, Genetic

Source

Identifiers

PMID: 10822344
DOI: 10.1038/sj.mp.4000688

Genes

IMPA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).PMID 10822344Read ↗

A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients.Semantic proximity Read ↗

A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.Semantic proximity Read ↗

Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures.Semantic proximity Read ↗

Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.Semantic proximity Read ↗

Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples.Semantic proximity Read ↗

Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder.Semantic proximity Read ↗

A homozygous loss-of-function mutation in inositol monophosphatase 1 (IMPA1) causes severe intellectual disability.Semantic proximity Read ↗

A promoter polymorphism rs2075824 within IMPA2 gene affecting the transcription activity: possible relationship with schizophrenia.Semantic proximity Read ↗

C18orf1 located on chromosome 18p11.2 may confer susceptibility to schizophrenia.Semantic proximity Read ↗

A novel CpG-associated brain-expressed candidate gene for chromosome 18q-linked bipolar disorder.Semantic proximity Read ↗

Human MIP synthase splice variants in bipolar disorder.Semantic proximity Read ↗

Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.